[
  {
    "date": "2023-06-30",
    "symbol": "IMRN",
    "period": "FY",
    "revenuefromcontractswithcustomers": 1804705,
    "costofsales": 495558,
    "grossprofit": 1309147,
    "otherincome": 2591498,
    "fairvalueadjustmenttofinancialasset": 523666,
    "othergainslosses": 363724,
    "impairmentlossimpairmentgainandreversalofimpairmentlossdeterminedinaccordancewithifrs9": -430932,
    "generalandadministrativeexpense": 4220905,
    "researchanddevelopmentexpense": 2592145,
    "salesandmarketingexpense": 927423,
    "profitlossfromoperatingactivities": -3568838,
    "incomefinance": -116323,
    "costoffinance": -9652,
    "financecostsnet": -106671,
    "shareofprofitlossofassociatesandjointventuresaccountedforusingequitymethod": -324340,
    "profitlossbeforetax": -3786507,
    "profitloss": -3786507,
    "othercomprehensiveincomenetoftaxexchangedifferencesontranslation": -1012,
    "comprehensiveincome": -3787519,
    "basicearningslosspershare": -1.66,
    "dilutedearningslosspershare": -1.66,
    "cashandcashequivalents": 17159764,
    "tradeandothercurrentreceivables": 417420,
    "inventories": 839968,
    "othernoncurrentfinancialassets": 1834034,
    "othercurrentassets": 158151,
    "currentassets": 20409337,
    "investmentaccountedforusingequitymethod": 159066,
    "propertyplantandequipment": 200133,
    "noncurrentinventories": 1219646,
    "noncurrentassets": 1578845,
    "assets": 21988182,
    "tradeandothercurrentpayables": 1192769,
    "employeebenefitobligation": 289408,
    "currenttaxliabilitiescurrent": 698195,
    "othercurrentliabilities": 38767,
    "currentliabilities": 2219139,
    "employeebenefitobligationnoncurrent": 1882,
    "othernoncurrentliabilities": 150325,
    "noncurrentliabilities": 152207,
    "liabilities": 2371346,
    "netassetsliabilities": 19616836,
    "issuedcapital": 88436263,
    "capitalreserve": 3235969,
    "retainedearnings": -72055396,
    "equity": 19616836,
    "othercomprehensiveincomebeforetax": -1012,
    "remeasurementofoptionsissuedinpriorperiod": 104753,
    "optionswarrantslapsedexpired": -156392,
    "sharebasedpaymentexpenses": 122201,
    "receiptsfromsalesofgoodsandrenderingofservices": 1912689,
    "paymentstosuppliersforgoodsandservice": -7842052,
    "otherinflowsoutflowsofcashclassifiedasoperatingactivities": 251986,
    "revenuefromgovernmentgrants": 3082182,
    "cashflowsfromusedinoperatingactivities": -2595195,
    "purchaseofpropertyplantandequipmentclassifiedasinvestingactivities": 7739,
    "paymentsforacquisitionofassociate": 2729863,
    "interestreceivedclassifiedasinvestingactivities": 116323,
    "cashflowsfromusedininvestingactivities": -2621279,
    "paymentsofleaseliabilitiesclassifiedasfinancingactivities": 35015,
    "interestpaidclassifiedasfinancingactivities": 9652,
    "cashflowsfromusedinfinancingactivities": -44667,
    "increasedecreaseincashandcashequivalents": -5261141,
    "effectofexchangeratechangesoncashandcashequivalents": 310627,
    "descriptionofaccountingpolicyforprinciplesofconsolidationexplanatorypolicytextblock": "(b) Principles of consolidation and equity accounting",
    "descriptionofaccountingpolicyforinvestmentsotherfinancialassets": "(n) Investments and other financial assets",
    "descriptionofaccountingpolicyforequitypolicytextblock": "(s) Contributed equity",
    "descriptionofaccountingpolicyforroundingofamountspolicytextblock": "(u) Rounding of amounts",
    "descriptionofaccountingpolicyforgoodsandservicestaxexplanatory": "(v) Goods and services tax (GST)",
    "disclosureofunusedtaxlossesforwhichnodeferredtaxassetrecognizedtextblock": "30 June 2023 A$      30 June  2022 A$       Unused tax losses for which no deferred tax asset has been recognized      52,625,541       47,764,119       Potential tax benefit @ 25% (2022: 25%)      13,156,385       11,941,030",
    "disclosureofdetailedinformationofrelatedpartyexplanatory": "The aggregate compensation made to Directorsand Other Key Management Personnel of the Company is set out below:",
    "scheduleofleasesinbalancesheettabletextblock": "The balance sheet shows the following amounts relating to leases:",
    "scheduleofstatementofprofitorlosstabletextblock": "The statement of profit or loss shows the following amounts relatingto leases:",
    "scheduleofprovisionforsalesreturnstabletextblock": "2023 A$      2022 A$       Sales return provision due to the ongoing COVID-19 pandemic                    Carrying amount at the start of the year      95,931       213,024       Sales return provision (reversed)/recognized      (61,466)      71,025       Sales return made during the year      (34,465)      (188,118)      Carrying amount at the end of the year      -       95,931",
    "disclosureofordinarysharesexplanatory": "Movements in ordinary shares:",
    "disclosureofdetailedinformationotherreserve": "Thefollowing table shows a breakdown of the consolidated statement of financial position line item ‘other reserves’ and themovements in these reserves during the year",
    "disclosureofdetailedinformationmovementsinoptionsandwarrants": "Movements in options/warrants and performance rights:",
    "disclosuresofproductsandservicesexplanatory": "The segment information for the reportable segmentsfor the year ended June 30, 2023 is as follows:",
    "disclosureofreconciliationofcashflowfromoperationswithlossafterincometaxexplanatory": "Reconciliation of cash flow from operations with loss after income tax",
    "disclosureofnumberandweightedaverageexercisepricesofshareoptionstabularexplanatory": "Set out below are summaries of all listed andunlisted options, including those issued under OIP:",
    "scheduleofshareoptionsoutstanding": "Share options outstanding at the end of the yearhave the following expiry date and exercise prices:",
    "scheduleofdeemedvaluationofoptionsexplanatory": "The model inputs for options granted under OIPduring the year ended June 30, 2022 included:",
    "scheduleoftotalexpensesarisingfromsharebasedpaymenttransactions": "Total expenses arising from share-based paymenttransactions recognized during the period were as follows:",
    "disclosureofinformationaboutotherrelatedpartytransactionsexplanatory": "The following transactions occurred with relatedparties:",
    "disclosureoffinancialassetsandliabilitiesaresubjecttoforeigncurrencyrisktableexplanatory": "The group’s exposure to foreign currencyrisk at the end of the reporting period, expressed in Australian dollars, was as follows:",
    "disclosureofexchangeratetableexplanatory": "The variable for each currency the group is materially exposed to islisted below:",
    "disclosureoftradeandotherreceivablestableexplanatory": "On that basis, the loss allowance as at June30, 2023 was determined as follows for trade receivables:",
    "disclosureoftradeandotherpayablestableexplanatory": "The tables below analyze the group’s financialliabilities into relevant maturity groupings based on their contractual maturities. The amounts disclosed in the table are the contractualdiscounted cash flows.",
    "disclosureofofauditorremunerationtabletextblock": "The following table setsforth, for each of the years indicated, the fees billed by Grant Thornton Audit Pty Ltd.",
    "revenuefromcontractswithcustomer": 1804705,
    "revenueandoperatingincome": 1804705,
    "australianfederalrdtaxconcessionrefund": 392877,
    "mtecrdgrant": 2158936,
    "emdggrant": 28000,
    "otherincomeexpensefromsubsidiariesjointlycontrolledentitiesandassociates": 11685,
    "otherincomefromnonoperatingactivities": 2591498,
    "fairvalueadjustmentstofinancialassets": -523666,
    "netforeignexchangegainloss": 363724,
    "movementininventoryprovision": 430932,
    "accountingandaudit": 657970,
    "baddebts": 2376,
    "consultingexpenses": 23241,
    "depreciationandamortisationexpense": 48662,
    "otheremployeeexpense": 1874963,
    "expectedcreditlosses": 19111,
    "insuranceexpense": 434699,
    "investorrelationsexpenses": 194754,
    "legalexpenses": 233243,
    "listingandshareregistry": 152954,
    "superannuationexpenses": 141539,
    "travelexpense": 105535,
    "sharebasedpaymentexpense": 104753,
    "sharebasedpaymentexpensesperformancerights": 122201,
    "otherexpensebynature": 104904,
    "researchanddevelopmentconsultingexpenses": 111530,
    "propertydevelopmentandprojectmanagementexpense": 2480615,
    "sellingexpense": 192878,
    "marketingexpenses": 474926,
    "distributioncosts": 259619,
    "unusedtaxlossesforwhichnodeferredtaxassetrecognised": 52625541,
    "currenttaxexpenseincomeandadjustmentsforcurrenttaxofpriorperiods": 13156385,
    "applicabletaxrate": 0.25,
    "lossfromcontinuingoperationsbeforeincometaxexpense": -3786507,
    "currenttaxexpenseincome": -946627,
    "taxeffectofresearchanddevelopmenttaxincentive": -98219,
    "taxeffectofaccountingexpendituresubjecttoresearchanddevelopmenttaxincentive": 225791,
    "taxeffectofsharebasedpayments": 56738,
    "taxeffectofexpensenotdeductibleindeterminingtaxableprofittaxlosses": 453038,
    "taxeffectoftaxpayable": -1215355,
    "deferredtaxexpenseincomeunrecognisedinprofitorloss": 1215355,
    "taxrateeffectofforeigntaxrates": 0.25,
    "keymanagementpersonnelcompensationshorttermemployeebenefits": 1394154,
    "keymanagementpersonnelcompensationpostemploymentbenefits": 5283,
    "keymanagementpersonnelcompensationotherlongtermbenefits": 8110,
    "keymanagementpersonnelcompensationsharebasedpayment": 200753,
    "keymanagementpersonnelcompensation": 1608300,
    "profitlossattributabletoordinaryequityholdersofparententityincludingdilutiveeffects": 3786507,
    "weightedaveragenumberofshares": 227798346,
    "cash": 17159764,
    "cashequivalents": 17159764,
    "tradereceivables": 46949,
    "deferredtaxassets": 27920,
    "accruedincomeotherthancontractassets": 398391,
    "tradeandotherreceivables": 417420,
    "expecteddividendshareoptionsgranted": 2158936,
    "othercurrentreceivables": 1612414,
    "currenttradereceivables": 1834034,
    "increasedecreasethroughforeignexchangeandothermovementsfinancialassets": 221620,
    "deferredtaxrelatingtoitemschargedorcrediteddirectlytoequity": -523666,
    "commitmentsfordevelopmentoracquisitionofbiologicalassets": 731844,
    "netforeignexchangegain": 13442,
    "financialassets": 221620,
    "valuedate": "2023-06-30",
    "expirydate": "2023-07-31",
    "exercisepriceshareoptionsgranted2019": 2,
    "dilutiveeffectofshareoptionsonnumberofordinaryshares": 735000,
    "weightedaverageexercisepriceofshareoptionsgrantedinsharebasedpaymentarrangement2019": 1.85,
    "expectedvolatilityshareoptionsgranted": 1,
    "riskfreeinterestrateshareoptionsgranted": 0.0418,
    "exercisepriceofoutstandingshareoptions2019": 0.1583,
    "currentprepayments": 158151,
    "currentprepaymentsandcurrentaccruedincomeincludingcurrentcontractassets": 158151,
    "tradeandotherpayablestotradesuppliers": 790919,
    "accruals": 394026,
    "otherpayables": 7824,
    "tradeandotherpayables": 1192769,
    "deferredtaxexpenseincomerecognisedinprofitorloss": 698195,
    "otherdeferredincometotal": 698195,
    "plantandequipment": 19513,
    "fixtureandfittings": 137,
    "rightuseassets": 207086,
    "propertyplantandequipments": 226736,
    "inventoriestotal": 1108256,
    "definedbenefitobligationatpresentvalue": 237328,
    "transactionpriceallocatedtoremainingperformanceobligations": 52080,
    "employeebenefitobligations": 289408,
    "rightofuseassets": 180078,
    "totalrightofuseassets": 180078,
    "currentleaseliabilities": 38767,
    "noncurrentleaseliabilities": 150325,
    "leaseliabilities": 189092,
    "receivablesfromsaleofproperties": 41328,
    "depreciationrightofuseassets": 41328,
    "interestexpenseonleaseliabilities": 9652,
    "cashoutflowforleases": 35015,
    "countryofincorporationorresidenceofsubsidiary": "Australia",
    "proportionofownershipinterestinsubsidiary": 1,
    "currentinvestments": 404117,
    "purchaseoftreasuryshares": 79289,
    "shareoflossafterincometax": -324340,
    "totalcarryingamount": 159066,
    "numberofsharesoutstanding": 17.5,
    "increasedecreasethroughtransfersandotherchangesotherprovisions": -61466,
    "adjustmentsforprovisions": -34465,
    "numberofsharesissued": 227798346,
    "amountofordinaryshares": 88436263,
    "ordinaryshare": 227798346,
    "issueofequitytoordinaryvalue": 88436263,
    "otherreserves": 3123759,
    "othercomprehensiveincomebeforetaxgainslossesonremeasurementsofdefinedbenefitplans": -1012,
    "optionsandwarrantsissuedexpensed": 104753,
    "optionandwarrantsforfeited": -156392,
    "performancerightsissuedexpensedindollars": 122201,
    "currencytranslationdifferences": -1012,
    "sharesreservedforissueunderoptionsandcontractsforsaleofshares": 12879720,
    "valuereservedforissueunderoptionsandcontractsforsaleofshares": 3123759,
    "sharebasedpaymentsexpensesoptions": 1430000,
    "sharebasedpaymentsexpensesoption": 104753,
    "numberofsharesissuelapseofunexercisedoptions": -8424157,
    "lapseofunexerciseoptions": -156392,
    "sharebasedpaymentsexpensesperformancerights": 122201,
    "hyperimmuneproductsrevenue": 1804705,
    "grossprofits": 1309147,
    "gainslossesonfinancialassetsatfairvaluethroughprofitorloss": 523666,
    "expensefromsharebasedpaymenttransactionsinwhichgoodsorservicesreceiveddidnotqualifyforrecognitionasassets": -460251,
    "sellingandmarketingexpenses": -927423,
    "financeincome": 116323,
    "financecosts": 9652,
    "profitlossattributabletoownersofparent": -500583,
    "segmentassets": 398391,
    "segmentliabilities": 604018,
    "revenue": 1100725,
    "revenueformcontractwithcustomer": 626107,
    "adjustmentsfordepreciationandamortisationexpense": 48662,
    "adjustmentsforfinancecosts": 9652,
    "adjustmentsforfinanceincome": 116323,
    "leaveprovisionexpense": 27235,
    "sharebasedpaymentsexpense": 226954,
    "adjustmentsforunrealisedforeignexchangelossesgains": -422881,
    "adjustmentsfordecreaseincreaseintradeandotherreceivables": 226365,
    "adjustmentsfordecreaseincreaseininventories": -776100,
    "adjustmentsfordecreaseincreaseinotherassets": 414249,
    "adjustmentsfordecreaseincreaseinfinancialassetsheldfortrading": 848006,
    "adjustmentsforincreasedecreaseintradeandotherpayables": 31876,
    "adjustmentsforincreasedecreaseinotheroperatingpayables": 654506,
    "weightedaverageexercisepriceofshareoptionsoutstandinginsharebasedpaymentarrangement1": 0.27,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsvestednumberofshare01": 19873877,
    "weightedaverageexercisepriceofshareoptionsgrantedinsharebasedpaymentarrangement1": 0.12,
    "numberofshareoptiongrantedinsharebasedpaymentarrangement": 1430000,
    "weightedaverageexercisepriceofshareoptionsforfeitedinsharebasedpaymentarrangement1": 0.48,
    "numberofshareoptionforfeitedinsharebasedpaymentsarrangement": -8424157,
    "numberofoutstandingshareoption": 12879720,
    "averageexercisepricepershareoptionvestedandexercisable": 0.27,
    "numberofshareoptionexercisableinsharebasedpaymentarrangement": 12610802,
    "shareoptionsoutstanding": 173600,
    "shareoptionspershare": 1.35,
    "optionsissuedunderesop": 104753,
    "performancerightsissued": 122201,
    "totalexpenses": 226954,
    "purchasesofgoodsrelatedpartytransactions": 17065,
    "othertransactionswithkeymanagementrelatedpartytransactions": 44667,
    "paymentstosuppliersforgoodsandservicesandtoandonbehalfofemployees": 55000,
    "othercashandcashequivalents": 4770507,
    "tradereceivable": 46821,
    "tradeandotherpayablestotradesupplier": 577644,
    "othercurrentfinancialliabilities": 5394972,
    "impactonlossforperiods": 312908,
    "impactonothercomponentofequity": 37,
    "expectedcreditlossrate": 0.5942,
    "grosscarryingamount": 44345,
    "lossonallowancetradereceivable": 26352,
    "tradeandotherpayable": 798743,
    "grossleaseliabilities": 19165,
    "financialliabilities": 817908,
    "noncurrentbiologicalassets": 1580065,
    "otherassets": 21929061,
    "otherliabilities": 2366188,
    "accumulatedothercomprehensiveincome": -71997149,
    "othercomprehensiveincomenetoftaxcashflowhedges": 3700827,
    "auditorsremunerationforauditservices": 241583,
    "auditorsremunerationforauditservice": 241583,
    "revenuefromrenderingofinformationtechnologyconsultingservices": 3000,
    "consutingservicetotal": 3000,
    "numberofreportablesegment": 2,
    "percentageofentitysrevenue": 0.15,
    "usefullivesordepreciationratespropertyplantandequipmentperiod": "P2Y",
    "netimpairmentgains": 430932,
    "currentadvancestosuppliers": 444905,
    "remainingbalances": 111390,
    "remainingbalance": 1108256,
    "otherfinanceincome": 398391,
    "recogniseincome": 5514,
    "otherincomeofresearchanddevelopment": 5514,
    "mtecrdgrantresearchanddevelopmentgrant": 2158936,
    "emdggrantinotherincome": 28000,
    "shareoptions": 735000,
    "totalexerciseprice": 1470000,
    "expiredate": "2023-07-31",
    "receivedshares": 457577,
    "exceedsrevenue": 3191732,
    "sharespercentage": 1,
    "weightedaverageexercisepriceofshareoptionsexercisableinsharebasedpaymentarrangement2019": 1.85,
    "stockredeemedorcalledduringperiodshare": 457577,
    "otherrevenue": 1000000,
    "considerationpaidreceived": 2857131,
    "otherincome1": 2158936,
    "deferredtaxexpenseincome": 698195,
    "gainslossesonsubsequentincreaseinfairvaluelesscoststosellnotinexcessofrecognisedcumulativeimpairmentloss": 430932,
    "currentprovisions": 237328,
    "leasesoutflowcash": 9652,
    "percentageofvotingequityinterestsacquired": 0.175,
    "proceedsfromexerciseofoptions": 735000,
    "numberofsharesunlistedoption": 1000000,
    "performancerightsdescription": 3,
    "percentageofentityrevenue": 0.1,
    "rentalexpense": 38940,
    "percentageofforeignexchangerates": 0.058,
    "tradereceivable1": 46949,
    "tradereceivablespercentage": 0.026,
    "balancesoncurrentaccountsfromcustomers": 27920,
    "optionexercise": 735000,
    "entityregistrantname": "IMMURON LIMITED",
    "tradingsymbol": "IMRN",
    "documenttype": "20-F",
    "currentfiscalyearenddate": "--06-30",
    "entitycommonstocksharesoutstanding": 227798346,
    "amendmentflag": "false",
    "entitycentralindexkey": 1660046,
    "entitycurrentreportingstatus": "Yes",
    "entityvoluntaryfilers": "No",
    "entityfilercategory": "Non-accelerated Filer",
    "entitywellknownseasonedissuer": "No",
    "documentperiodenddate": "2023-06-30",
    "documentfiscalyearfocus": 2023,
    "documentfiscalperiodfocus": "FY",
    "entityemerginggrowthcompany": "false",
    "entityshellcompany": "false",
    "icfrauditorattestationflag": "false",
    "documentregistrationstatement": "false",
    "documentannualreport": "true",
    "documenttransitionreport": "false",
    "documentshellcompanyreport": "false",
    "entityfilenumber": "000-38104",
    "entityincorporationstatecountrycode": "C3",
    "entityaddressaddressline1": "Level 3, 62 Lygon Street",
    "entityaddressaddressline2": "Carlton South",
    "entityaddresscityortown": "Victoria",
    "entityaddresspostalzipcode": 3053,
    "entityaddresscountry": "AU",
    "contactpersonnelname": "Mr. Steven Lydeamore",
    "cityareacode": 61,
    "localphonenumber": "3 9822 7735",
    "security12btitle": "American Depositary Shares, each representing 40 Ordinary Shares",
    "securityexchangename": "NASDAQ",
    "entityinteractivedatacurrent": "Yes",
    "documentfinstmterrorcorrectionflag": "false",
    "documentaccountingstandard": "International Financial Reporting Standards",
    "auditorfirmid": 2233,
    "auditorname": "GRANT THORNTON AUDIT PTY LTD",
    "auditorlocation": "Melbourne, Australia"
  },
  {
    "date": "2022-06-30",
    "symbol": "IMRN",
    "period": "FY",
    "revenuefromcontractswithcustomers": 765193,
    "costofsales": 241691,
    "grossprofit": 523502,
    "otherincome": 24585,
    "othergainslosses": 247558,
    "generalandadministrativeexpense": 3524388,
    "researchanddevelopmentexpense": 657715,
    "salesandmarketingexpense": 416537,
    "profitlossfromoperatingactivities": -3112743,
    "incomefinance": -21785,
    "costoffinance": -6184,
    "financecostsnet": -15601,
    "profitlossbeforetax": -2854254,
    "profitloss": -2854254,
    "othercomprehensiveincomenetoftaxexchangedifferencesontranslation": 6708,
    "comprehensiveincome": -2854254,
    "basicearningslosspershare": -1.25,
    "dilutedearningslosspershare": -1.25,
    "cashandcashequivalents": 22110278,
    "tradeandothercurrentreceivables": 662896,
    "inventories": 37,
    "othercurrentassets": 572400,
    "currentassets": 23672152,
    "propertyplantandequipment": 226736,
    "noncurrentinventories": 956936,
    "noncurrentassets": 1183672,
    "assets": 22909414,
    "tradeandothercurrentpayables": 1160893,
    "currentprovisionsforemployeebenefits": 95931,
    "employeebenefitobligation": 211776,
    "othercurrentliabilities": 34376,
    "currentliabilities": 1502976,
    "employeebenefitobligationnoncurrent": 36,
    "othernoncurrentliabilities": 175411,
    "noncurrentliabilities": 175447,
    "liabilities": 1521219,
    "netassetsliabilities": 23177401,
    "issuedcapital": 88436263,
    "capitalreserve": 3166419,
    "retainedearnings": -68425281,
    "equity": 23177401,
    "equitybalance": 23177401,
    "othercomprehensiveincome": 6708,
    "sharesissuednetofcosts": 74960,
    "optionsorwarrantsissuedexpensed": 54930,
    "optionswarrantsforfeitedindollars": 361861,
    "receiptsfromsalesofgoodsandrenderingofservices": 696603,
    "paymentstosuppliersforgoodsandservice": -4629139,
    "otherinflowsoutflowsofcashclassifiedasoperatingactivities": 306154,
    "revenuefromgovernmentgrants": 478589,
    "cashflowsfromusedinoperatingactivities": -3147793,
    "purchaseofpropertyplantandequipmentclassifiedasinvestingactivities": 10048,
    "interestreceivedclassifiedasinvestingactivities": 21785,
    "cashflowsfromusedininvestingactivities": 11737,
    "paymentsofleaseliabilitiesclassifiedasfinancingactivities": 36264,
    "interestpaidclassifiedasfinancingactivities": 6184,
    "cashflowsfromusedinfinancingactivities": -42448,
    "increasedecreaseincashandcashequivalents": -3178504,
    "effectofexchangeratechangesoncashandcashequivalents": 241501,
    "nonfinancialassetsandliabilitiestextblock": "Note 9. Non-financial assets and liabilities ",
    "controlledentitiestextblock": "Note10. Controlled Entities ",
    "disclosureofcashflowinformationexplanatorytextblock": "Note 16. Cash Flow Information ",
    "disclosureofparententityfinancialinformation": "Note 21. Parent entity financial information ",
    "disclosureofcompanydetailsexplanatory": "Note 23. Company Details ",
    "descriptionofaccountingpolicyforbasisofpresentation": "  (a) Basis of preparation   ",
    "descriptionofaccountingpolicyforprinciplesofconsolidationexplanatorypolicytextblock": "  (b) Principles of consolidation  ",
    "descriptionofaccountingpolicyforinvestmentsotherfinancialassets": "(n)Investments and other financial assets ",
    "descriptionofaccountingpolicyforequitypolicytextblock": "(s)Contributed equity ",
    "descriptionofaccountingpolicyforroundingofamountspolicytextblock": "(u)Rounding of amounts ",
    "descriptionofaccountingpolicyforgoodsandservicestaxexplanatory": "(v)Goods and services tax (GST) ",
    "disclosureofunusedtaxlossesforwhichnodeferredtaxassetrecognizedtextblock": "            30 June 2022 A$      30 June  2021 A$       Unused tax losses for which no deferred tax asset has been recognized      48,058,129       44,178,579       Potential tax benefit @ 25% (2021: 26%)      12,014,532       11,486,431    ",
    "scheduleofprovisionforsalesreturnstextblock": "            2022 A$      2021 A$       Sales return provision due to the ongoing COVID-19 pandemic                    Carrying amount at the start of the year      213,024       -       Sales return provision recognized      71,025       213,024       Sales return made during the year      (188,118)      -       Carrying amount at the end of the year      95,931       213,024    ",
    "scheduleoftotalexpensesarisingfromsharebasedpaymenttransactions": "            2022 A$      2021 A$      20201 A$       Options issued under OIP      54,930       1,970,100       (607,000)      Shares issued under OIP      39,960       -       -       Share-based payments to KMP2      -       145,913       73,088              94,890       2,116,013       (533,912)   ",
    "disclosureofinformationaboutotherrelatedpartytransactionsexplanatory": "            2022 A$      2021 A$      2020 A$                                   Amounts settled in cash or shares for goods and services                              Purchases of various goods and services from entities controlled by key management personnel (i)      154,364       110,607       142,347       Legal services by key management personnel (ii)      20,000       -       -   ",
    "disclosureofexchangeratetableexplanatory": "            Impact on loss for the period      Impact on other components of equity             2022 A$      2021 A$      2022 A$      2021 A$       USD/AUD exchange rate – change by 5.8% (2021: 4.9%)      202,507       136,467       6,567       5,219    ",
    "disclosureoftradeandotherreceivablestableexplanatory": "            Days past due             Current      1-30      31-60      61-90      91-120      121+      Total       30 June 2022     A$      A$      A$      A$      A$      A$      A$       Expected credit loss rate      0.00%      0.00%      13.08%      24.14%      26.84%      0.00%              Gross carrying amount      -       -       7,959       664       186       -       8,809       Loss allowance      -       -       -       -       -       -       -    ",
    "disclosureofofauditorremunerationtabletextblock": "            Year Ended June 30,             2022 A$      2021 A$       Audit and review of financial statements (1)      173,631       179,742              173,631       179,742    ",
    "revenuefromcontractswithcustomer": 765193,
    "revenueandoperatingincome": 765193,
    "australianfederalrdtaxconcessionrefund": 257500,
    "researchanddevelopmentgrants": 306595,
    "mtecrdgrantresearchanddevelopmentgrant": 369045,
    "otherincomes": 24585,
    "otherincomefromnonoperatingactivities": 957725,
    "netforeignexchangegainloss": 247558,
    "accountingandaudit": 499331,
    "consultingexpenses": 226710,
    "depreciationandamortisationexpense": 42606,
    "otheremployeeexpense": 1212721,
    "expectedcreditlosses": 8809,
    "insuranceexpense": 401121,
    "investorrelationsexpenses": 38567,
    "legalexpenses": 520698,
    "listingandshareregistry": 164949,
    "superannuationexpenses": 62647,
    "travelexpense": 9459,
    "sharebasedpaymentexpense": 94890,
    "otherexpensebynature": 241880,
    "researchanddevelopmentconsultingexpenses": 230684,
    "propertydevelopmentandprojectmanagementexpense": 427031,
    "sellingexpense": 57854,
    "marketingexpenses": 113472,
    "distributioncosts": 245211,
    "unusedtaxlossesforwhichnodeferredtaxassetrecognised": 48058129,
    "currenttaxexpenseincomeandadjustmentsforcurrenttaxofpriorperiods": 12014532,
    "currenttaxexpenseincome": -713564,
    "taxeffectofresearchanddevelopmenttaxincentive": -64375,
    "taxeffectofaccountingexpendituresubjecttoresearchanddevelopmenttaxincentive": 147989,
    "taxeffectofsharebasedpayments": 23723,
    "taxeffectofexpensenotdeductibleindeterminingtaxableprofittaxlosses": -363661,
    "taxeffectoftaxpayable": -969888,
    "deferredtaxexpenseincomeunrecognisedinprofitorloss": 969888,
    "keymanagementpersonnelcompensationshorttermemployeebenefits": 636673,
    "keymanagementpersonnelcompensationpostemploymentbenefits": 44489,
    "keymanagementpersonnelcompensationotherlongtermbenefits": 15168,
    "keymanagementpersonnelcompensationsharebasedpayment": 94890,
    "keymanagementpersonnelcompensation": 791220,
    "basicanddilutedearningslosspershare": -1.25,
    "profitlossattributabletoordinaryequityholdersofparententityincludingdilutiveeffects": 2854254,
    "weightedaveragenumberofshares": 227579684,
    "cash": 22110278,
    "cashequivalents": 22110278,
    "tradereceivables": 217154,
    "lossonallowancetradereceivables": -8809,
    "accruedincomeotherthancontractassets": 257500,
    "otherincomereceivables": 197051,
    "tradeandotherreceivables": 662896,
    "currentprepayments": 572400,
    "currentprepaymentsandcurrentaccruedincomeincludingcurrentcontractassets": 572400,
    "tradeandotherpayablestotradesuppliers": 720867,
    "accruals": 411913,
    "otherpayables": 28113,
    "tradeandotherpayables": 1160893,
    "plantandequipment": 19513,
    "fixtureandfittings": 137,
    "rightuseassets": 207086,
    "propertyplantandequipments": 226736,
    "inventoriesnet": 1283514,
    "definedbenefitobligationatpresentvalue": 211812,
    "rightofuseassets": 207086,
    "currentleaseliabilities": 34376,
    "noncurrentleaseliabilities": 175411,
    "leaseliabilities": 209787,
    "depreciationrightofuseassets": 37937,
    "interestexpenseonleaseliabilities": 6100,
    "cashoutflowforleases": 36264,
    "proportionofownershipinterestinsubsidiary": 1,
    "provisions": 95931,
    "increasedecreasethroughtransfersandotherchangesotherprovisions": 71025,
    "adjustmentsforprovision": -188118,
    "numberofsharesissued": 227798346,
    "amountofordinaryshares": 88436263,
    "ordinaryshare": 227798346,
    "issueofequitytoordinaryvalue": 88436263,
    "issueat012underesopplan20211105": 333000,
    "issueat012underesopplan2021110": 39960,
    "issueat016inlieuofpaymentforservices20211217": 218750,
    "issueat016inlieuofpaymentforservices2021121": 35000,
    "otherreserves": 3166419,
    "optionsandwarrantsissuedexpensed": 54930,
    "optionandwarrantsforfeited": -361861,
    "currencytranslationdifferences": 6708,
    "sharesreservedforissueunderoptionsandcontractsforsaleofshares": 19873877,
    "valuereservedforissueunderoptionsandcontractsforsaleofshares": 3053197,
    "lapseofunexercisedoptionsvalueone": -1200000,
    "lapseofunexercisedoptionsvaluefour": -188400,
    "valueissueemployeestockownershipplanthree": 500000,
    "issueofemployeestockoptionplanthree": 18624,
    "numberofsharesissuelapseofunlistedoptionsix": -14493,
    "lapseofunexercisedoptionssix": -28813,
    "lapseofunexercisedoptionstwo": -24721108,
    "intangibleassetsandgoodwill": 144648,
    "employeestockownershipplanoptionvalue": 36306,
    "hyperimmuneproductsrevenue": 765193,
    "grossprofits": 523502,
    "expensefromsharebasedpaymenttransactionsinwhichgoodsorservicesreceiveddidnotqualifyforrecognitionasassets": -3524388,
    "sellingandmarketingexpenses": -416537,
    "financeincome": 21785,
    "financecosts": 6184,
    "profitlossattributabletoownersofparent": -2854254,
    "segmentassets": 24855824,
    "segmentliabilities": -1678423,
    "revenue": 765193,
    "revenueformcontractwithcustomer": 616732,
    "adjustmentsfordepreciationandamortisationexpense": 26613,
    "leasemodification": 15993,
    "adjustmentsfordistributioncosts": 35000,
    "adjustmentsforfinancecosts": 6184,
    "adjustmentsforfinanceincome": 21785,
    "leaveprovisionexpense": 45470,
    "sharebasedpaymentsexpense": 94891,
    "adjustmentsforunrealisedforeignexchangelossesgains": -234794,
    "adjustmentsfordecreaseincreaseintradeandotherreceivables": -336998,
    "adjustmentsfordecreaseincreaseininventories": 275605,
    "adjustmentsfordecreaseincreaseinotherassets": -494143,
    "adjustmentsforincreasedecreaseintradeandotherpayables": 285616,
    "weightedaverageexercisepriceofshareoptionsoutstandinginsharebasedpaymentarrangement1": 0.37,
    "numberofoutstandingshareoption": 19873877,
    "weightedaverageexercisepriceofshareoptionsgrantedinsharebasedpaymentarrangement1": 0.25,
    "numberofshareoptiongrantedinsharebasedpaymentarrangement": 500000,
    "weightedaverageexercisepriceofshareoptionsforfeitedinsharebasedpaymentarrangement1": 0.27,
    "numberofshareoptionforfeitedinsharebasedpaymentsarrangement": -25935601,
    "averageexercisepricepershareoptionvestedandexercisable": 0.37,
    "numberofshareoptionexercisableinsharebasedpaymentarrangement": 19538877,
    "sharebasedcompensationarrangementbysharebasedpaymentawardexpirationdate1": 0.12,
    "exerciseprice": 0.25,
    "shareoptionsoutstanding": 19873877,
    "shareoptionspershare": 1.54,
    "sharebasedcompensationarrangementbysharebasedpaymentawardawardgrantdate": "2026-06-27",
    "exercisepriceshareoptionsgranted1": 1930000,
    "numberofinstrumentotherequityinstrumentgranted": 0.07,
    "descriptionofexpectedvolatilityshareoptionsgranted": 1.281,
    "descriptionofriskfreeinterestrateshareoptionsgranted": 0.033100000000000004,
    "fairvalueatgrantdateperoption": 0.053,
    "optionsissuedunderesop": 54930,
    "sharesissuedunderoip": 39960,
    "totalexpenses": 94890,
    "purchasesofgoodsrelatedpartytransactions": 154364,
    "othertransactionswithkeymanagementrelatedpartytransactions": 154364,
    "legalservicesbykeymanagementpersonnel": 20000,
    "paymentstosuppliersforgoodsandservicesandtoandonbehalfofemployees": 77000,
    "othercashandcashequivalents": 3138079,
    "tradereceivable": 279986,
    "tradeandotherpayablestotradesupplier": 73430,
    "othercurrentfinancialliabilities": 3491495,
    "impactonlossforperiods": 202507,
    "impactonothercomponentofequity": 6567,
    "expectedcreditlossrate": 0.2684,
    "grosscarryingamount": 8809,
    "tradeandotherpayable": 748980,
    "grossleaseliabilities": 34376,
    "financialliabilities": 748980,
    "auditorsremunerationforauditservices": 173631,
    "auditorsremunerationforauditservice": 173631,
    "percentageofentitysrevenue": 0.1,
    "expecteddividendshareoptionsgranted": 369045,
    "usefullivesordepreciationratespropertyplantandequipmentperiod": 3,
    "remainingbalance": 956936,
    "otherfinanceincome": 96723,
    "otherincomeofresearchanddevelopment": 257500,
    "grouprecognizeddescription": "For the year ended 30 June 2022, the group has recognized $306,595 (2021: $74,821) R&D grantfrom the Henry M Jackson Foundation (“HJF”) and $369,045 (2021: Nil) R&D grant from Medical Technology Enterprise Consortium(“MTEC”).",
    "totalleaveprovision": 211776,
    "leasesoutflowcash": 6100,
    "paymentforservices": 70000,
    "parvaluepershare": 0.16,
    "numberofsegment": 2,
    "percentageofentityrevenue": 0.1,
    "optiongranteddescription": "Options granted to a former managing director on 11 February 2019 and valued at $975,000 in the 30 June 2019 financials were subject to shareholder approval. In line with IFRS 2, these were re-measured at grant date 6 November 2019 after being approved by shareholders with a value of $368,000, being a remeasurement of $607,000 in the 30 June 2020 financials.",
    "rentalexpense": 42364,
    "leaserenewed": "January 1, 2022",
    "warehousingdistributionandinvoicingservices": 70000,
    "sharesissuedpricepershare1": 0.16,
    "additionalpayable": 35000,
    "legalservices": 20000,
    "percentageofforeignexchangerates": 0.057999999999999996,
    "entityregistrantname": "IMMURON LIMITED",
    "tradingsymbol": "IMRN",
    "documenttype": "20-F",
    "currentfiscalyearenddate": "June 30",
    "entitycommonstocksharesoutstanding": 227798346,
    "amendmentflag": "false",
    "entitycentralindexkey": 1660046,
    "entitycurrentreportingstatus": "Yes",
    "entityvoluntaryfilers": "No",
    "entityfilercategory": "Non-accelerated filer",
    "entitywellknownseasonedissuer": "No",
    "documentperiodenddate": "June 30, 2022",
    "documentfiscalyearfocus": 2022,
    "documentfiscalperiodfocus": "FY",
    "entityemerginggrowthcompany": "false",
    "entityshellcompany": "true",
    "icfrauditorattestationflag": "false",
    "documentregistrationstatement": "false",
    "documentannualreport": "true",
    "documenttransitionreport": "false",
    "documentshellcompanyreport": "false",
    "entityfilenumber": "000-38104",
    "entityincorporationstatecountrycode": "Australia",
    "entityaddressaddressline1": "Level 3, 62 Lygon Street",
    "entityaddresscityortown": "Carlton South",
    "entityaddresspostalzipcode": 3053,
    "entityaddresscountry": "Australia",
    "contactpersonnelname": "Mr. Steven Lydeamore",
    "cityareacode": 61,
    "localphonenumber": "3 98227735",
    "security12btitle": "American Depositary Shares, each representing 40 Ordinary Shares",
    "securityexchangename": "The NASDAQ Stock Market LLC",
    "entityinteractivedatacurrent": "Yes",
    "documentaccountingstandard": "International Financial Reporting Standards",
    "auditorfirmid": 2233,
    "auditorname": "GRANT THORNTON AUDIT PTY LTD",
    "auditorlocation": "Melbourne, Australia"
  },
  {
    "date": "2021-06-30",
    "symbol": "IMRN",
    "period": "FY",
    "revenuefromcontractswithcustomers": 145776,
    "costofsales": 51071,
    "grossprofit": 94705,
    "otherincome": 161600,
    "othergainslosses": -582528,
    "generalandadministrativeexpense": 3978679,
    "sharebasedpaymentsexpenses": 2116013,
    "researchanddevelopmentexpense": 1367054,
    "salesandmarketingexpense": 287684,
    "profitlossfromoperatingactivities": -6515620,
    "incomefinance": -9204,
    "costoffinance": -13761,
    "financecostsnet": 4557,
    "profitlossbeforetax": -8384465,
    "profitloss": -8384465,
    "othercomprehensiveincomenetoftaxexchangedifferencesontranslation": -14953,
    "comprehensiveincome": -8384465,
    "basicanddilutedearningslosspershare": -3.79,
    "cashandcashequivalents": 108688,
    "tradeandothercurrentreceivables": 334707,
    "inventories": 292532,
    "othercurrentassets": 78258,
    "currentassets": 25752778,
    "propertyplantandequipment": 33741,
    "inventoriestotal": 1266587,
    "noncurrentassets": 1300328,
    "assets": 25159280,
    "tradeandothercurrentpayables": 758494,
    "currentprovisionsforemployeebenefits": 213024,
    "employeebenefitobligation": 129837,
    "othercurrentliabilities": 20498,
    "currentliabilities": 1121853,
    "employeebenefitobligationnoncurrent": 36196,
    "noncurrentliabilities": 36196,
    "liabilities": 629827,
    "netassetsliabilities": 25895057,
    "issuedcapital": 88361303,
    "otherreserves": 106514,
    "retainedearnings": -65932888,
    "equity": 25895057,
    "equitybalance": 25895057,
    "othercomprehensiveincomelossforperiod": -14953,
    "issueofequity": 24386005,
    "optionsorwarrantsissuedexpensed": 3003060,
    "optionsorwarrantsexercised": 1115585,
    "optionsorwarrantsforteitedlapsed": -368000,
    "stockissuedduringperiodvalueissuedtodirectors": 145912,
    "transfertosharecapital": -73088,
    "receiptsfromsalesofgoodsandrenderingofservices": 192185,
    "paymentstosuppliersforgoodsandservice": -4865633,
    "otherinflowsoutflowsofcashclassifiedasoperatingactivities": 358280,
    "revenuefromgovernmentgrants": 236421,
    "cashflowsfromusedinoperatingactivities": -4078747,
    "purchaseofpropertyplantandequipmentclassifiedasinvestingactivities": 6630,
    "interestreceivedclassifiedasinvestingactivities": 9204,
    "cashflowsfromusedininvestingactivities": 2574,
    "proceedsfromissuingshares": 29281421,
    "capitalcost": 2746871,
    "proceedsfromborrowingsclassifiedasfinancingactivities": 212794,
    "repaymentsofborrowingsclassifiedasfinancingactivities": 212794,
    "paymentsofleaseliabilitiesclassifiedasfinancingactivities": 40607,
    "interestpaidclassifiedasfinancingactivities": 13761,
    "cashflowsfromusedinfinancingactivities": 26480182,
    "increasedecreaseincashandcashequivalents": 22404009,
    "effectofexchangeratechangesoncashandcashequivalents": -607196,
    "disclosureofcashexplanatory": "Note 7. Cash ",
    "controlledentitiestextblock": "Note 10. Controlled Entities ",
    "disclosureofprovisionforsalesreturnsexplantory": "Note 12. Provision for Sales Returns ",
    "contingentliabilitiestextblock": "Note 13. Contingent liabilities and Commitments ",
    "disclosureofcashflowinformationexplanatorytextblock": "Note 18. Cash Flow Information ",
    "disclosureofcompanydetailsexplanatory": "Note 23. Company Details ",
    "descriptionofaccountingpolicyforbasisofpresentation": "  (a) Basis of preparation  ",
    "descriptionofaccountingpolicyforprinciplesofconsolidationexplanatorypolicytextblock": "(b)Principles of consolidation ",
    "descriptionofaccountingpolicyforaasbinterpretation23uncertaintyoverincometaxtreatmentstextblock": "   (h)  AASB Interpretation 23 Uncertainty over Income Tax Treatments  ",
    "descriptionofaccountingpolicyforinvestmentsotherfinancialassets": "(n)Investments and other financial assets ",
    "descriptionofaccountingpolicyforequitypolicytextblock": "(s)Contributed equity ",
    "descriptionofaccountingpolicyforroundingofamountspolicytextblock": "(u)Rounding of amounts ",
    "descriptionofaccountingpolicyforgoodsandservicestaxexplanatory": "(v)Goods and services tax (GST) ",
    "disclosureofunusedtaxlossesforwhichnodeferredtaxassetrecognizedtextblock": "            30                                            June                                            2021                                            A$      30    June 2020 A$       Unused tax losses for which no deferred tax asset has been recognised      44,178,579       40,018,956       Potential tax benefit @ 26% (2020: 27.5%)      11,486,431       11,005,213    ",
    "detailedinformationaboutcashexplanatory": "            30 June 2021      30 June 2020             A$      A$       Cash at Bank and in hand:                    Cash at bank and in hand      25,047,281       3,250,468       Total Cash      25,047,281       3,250,468   ",
    "detailedinformationabouttradeandotherreceivablesexplanatory": "            30 June 2021      30 June 2020             A$      A$                            Current                                         Trade receivables*      28,553       49,519       Loss allowance      -       (30,055)      Accrued income**      306,154       308,225       Total Trade and Other Receivables      334,707       327,689    ",
    "disclosureoftradeandothercurrentpayablestabletextblock": "            30                                            June 2021 A$      30                                            June 2020 A$                            Current                    Trade payables      106,893       157,644       Accrued expenses      625,980       210,734       Other payables      25,621       16,019       Total      758,494       384,397   ",
    "disclosureofsalesreturnprovisionexplantory": "      Sales return provision due to the ongoing COVID-19 pandemic     2021 A$       Carrying amount at the start of the year      -       Sales return provision recognised      213,024       Amounts transferred from non-current      -       Carrying amount at the end of the year      213,024    ",
    "scheduleofamountsrecognizedinbalancesheet": "            30                                            June 2021                                            A$      30                                            June 2020                                            A$       Right-of-use assets1                    Properties      19,471       58,095              19,471       58,095       Lease liabilities2                      Current      20,498       42,176       Non-current      -       18,929              20,498       61,105    ",
    "disclosureofinformationaboutotherrelatedpartytransactionsexplanatory": "            2021    A$      2020    A$      2019    A$                                   Amounts settled in cash or shares for goods    and services                              Purchases of various    goods and services from entities controlled by key management personnel (i)      110,607       142,347       147,636    ",
    "disclosureoffinancialassetsandliabilitiesaresubjecttoforeigncurrencyrisktableexplanatory": "            2021      2020             USD    $      CAD    $      USD $      CAD $      ILS $       Cash and cash equivalents      2,742,688       108,688       2,954,589       107,605       -       Trade receivables      23,801       -       45,591       -       -       Trade payables      18,556       43,466       29,946       1,923       41,771       Total exposure      2,785,045       152,154       3,030,126       109,528       41,771    ",
    "disclosureofexchangeratetableexplanatory": "            Impact    on loss for the period      Impact    on other components of equity             2021    A$      2020 A$      2021    A$      2020 A$       USD/AUD exchange rate – change by 4.9% (2020:    3.3%)      136,467       99,994       5,219       4,035    ",
    "disclosureoftradeandotherreceivablestableexplanatory": "            Days past due             Current      1-30      31-60      61-90      91-120      121+      Total       30 June 2021     A$      A$      A$      A$      A$      A$      A$       Expected credit loss rate      0.00%      0.00%      13.07%      21.88%      34.09%      53.58%              Gross carrying amount      23,801       4,752       -       -       -       -       28,553       Loss allowance      -       -       -       -       -       -       -    ",
    "revenueandoperatingincome": 145776,
    "australianfederalrdtaxconcessionrefund": 356209,
    "othergovernmentassistanceincome": 161600,
    "researchanddevelopmentgrants": 74821,
    "otherincomes": 24480,
    "otherincomefromnonoperatingactivities": 617110,
    "netforeignexchangegainloss": -582528,
    "impairmentloss": 759765,
    "accountingandaudit": 547055,
    "baddebts": 5472,
    "consultingexpenses": 126215,
    "depreciationandamortisationexpense": 43662,
    "otheremployeeexpense": 1775809,
    "expectedcreditlosses": -30055,
    "insuranceexpense": 341202,
    "investorrelationsexpenses": 38568,
    "legalexpenses": 205722,
    "listingandshareregistry": 292113,
    "superannuationexpenses": 41964,
    "travelexpense": 1398,
    "otherexpensebynature": 589554,
    "researchanddevelopmentconsultingexpenses": 1006086,
    "propertydevelopmentandprojectmanagementexpense": 360968,
    "sellingexpense": 25858,
    "marketingexpenses": 90652,
    "distributioncosts": 171174,
    "unusedtaxlossesforwhichnodeferredtaxassetrecognised": 44178579,
    "currenttaxexpenseincomeandadjustmentsforcurrenttaxofpriorperiods": 11486431,
    "currenttaxexpenseincome": -2179961,
    "taxeffectofresearchanddevelopmenttaxincentive": -92614,
    "taxeffectofaccountingexpendituresubjecttoresearchanddevelopmenttaxincentive": 212907,
    "taxeffectofsharebasedpayments": 550163,
    "taxeffectofexpensenotdeductibleindeterminingtaxableprofittaxlosses": 428003,
    "taxeffectoftaxpayable": -1081502,
    "deferredtaxexpenseincomeunrecognisedinprofitorloss": 1081502,
    "keymanagementpersonnelcompensationshorttermemployeebenefits": 450002,
    "keymanagementpersonnelcompensationothershorttermbenefitsincludingconsultingservicesrelatedentities": 1603747,
    "keymanagementpersonnelcompensationpostemploymentbenefits": 27869,
    "keymanagementpersonnelcompensationotherlongtermbenefits": 8220,
    "keymanagementpersonnelcompensationsharebasedpayment": 2116012,
    "keymanagementpersonnelcompensation": 4205850,
    "profitlossattributabletoordinaryequityholdersofparententityincludingdilutiveeffects": 8384465,
    "weightedaveragenumberofshares": 221062229,
    "cashatbankandinhand": 25047281,
    "cash": 25047281,
    "tradereceivables": 23801,
    "accruedincomeotherthancontractassets": 306154,
    "tradeandotherreceivables": 334707,
    "noncurrentinventories": 1266587,
    "inventoriesnet": 1559119,
    "countryofincorporationorresidenceofsubsidiary": "Canada",
    "proportionofownershipinterestinsubsidiary": 1,
    "tradeandotherpayablestotradesuppliers": 43466,
    "accruals": 625980,
    "otherpayables": 25621,
    "tradeandotherpayables": 758494,
    "provisions": 213024,
    "increasedecreasethroughtransfersandotherchangesotherprovisions": 213024,
    "rightofuseassets": 19471,
    "currentleaseliabilities": 20498,
    "leaseliabilities": 20498,
    "depreciationrightofuseassets": 38624,
    "interestexpenseonleaseliabilities": 1152,
    "cashoutflowforleases": 40607,
    "numberofsharesissued": 227246596,
    "amountofordinaryshares": 88361303,
    "ordinaryshare": 227246596,
    "issueofequitytoordinaryvalue": 88361303,
    "exerciseofrepresentativewarrants1": 5720,
    "issueatus047pursuanttoadspublicoffering": 42666720,
    "issueatus047pursuanttoadspublicoffering1": 28165836,
    "issueat050onexerciseofesopunlistedoption": 100000,
    "issueat050onexerciseofesopunlistedoptions": 50000,
    "issueatus025onexerciseofnasdaqwarrants": 3008000,
    "issueatus025onexerciseofnasdaqwarrants1": 1051626,
    "issueatus025onexerciseofnasdaqwarrant": 40000,
    "issueatus025onexerciseofnasdaqwarrant1": 13959,
    "transferfromreservesonexerciseofesopunlistedoption": 15700,
    "transferfromreservesonexerciseofnasdaqwarrants": 1012,
    "issueata008inlieuofcashforservicesrendered20201113": 2737500,
    "issueata008inlieuofcashforservicesrendered": 219000,
    "transferfromreservesoncashlessexerciseofesopunlistedoptions20210209": 409090,
    "transferfromreservesoncashlessexerciseofesopunlistedoptions": 197010,
    "businessacquisitioncostoftransactioncost": -3779831,
    "othercomprehensiveincome": -14953,
    "transfertosharecapitalindollars": -73088,
    "optionsandwarrantsissuedexpensed": 3003060,
    "optionsandwarrantsexercised": -213722,
    "optionsandwarrantsforfeited": -368000,
    "currencytranslationdifferences": -14953,
    "sharesreservedforissueunderoptionsandcontractsforsaleofshares": 45309478,
    "valuereservedforissueunderoptionsandcontractsforsaleofshares": 3360128,
    "exerciseofrepresentativewarrantssharesone": -9640,
    "exerciseofesopunlistedoptions": -100000,
    "exerciseofesopunlistedoptionsvalue": -15700,
    "exerciseofnasdaqwarrantsatusdtenperfortyoptionssharesone": -3048000,
    "exerciseofnasdaqwarrantsatusdtenperfortyoptionsone": -1012,
    "lapseofunexercisedoptionsone": -5000000,
    "lapseofunexercisedoptionsvalue": -368000,
    "issueofrepresentativewarrantsthreeshares": 2560000,
    "issueofrepresentativewarrantsthree": 1032960,
    "numberofsharesissueemployeestockownershipplanunlistedoptionthree": 9000000,
    "valueissuedemployeestockownershipplanunlistedoptionthree": 1970100,
    "cashlessexerciseofesopunlistedoptions": -900000,
    "cashlessexerciseofesopunlistedoptionsvalue": -197010,
    "reclassifysharebasedpaymentsexpensesfromreservestosharecapitalvalue": -73088,
    "hyperimmuneproductsrevenue": 145776,
    "generalandadministrativeexpenses": 3978679,
    "expensefromsharebasedpaymenttransactionsinwhichgoodsorservicesreceiveddidnotqualifyforrecognitionasassets": -2116013,
    "sellingandmarketingexpenses": -287684,
    "financeincome": 9204,
    "financecosts": 13761,
    "profitlossattributabletoownersofparent": -8384465,
    "segmentassets": 27053106,
    "segmentliabilities": -1158049,
    "revenue": 145776,
    "revenuefromexternalcustomers": 145776,
    "revenueformcontractwithcustomer": 140022,
    "adjustmentsforfinancecosts": 13761,
    "adjustmentsforfinanceincome": 9204,
    "leaveprovisionexpense": 53610,
    "sharebasedpaymentsexpense": 2116013,
    "adjustmentsforunrealisedforeignexchangelossesgains": 592243,
    "adjustmentsfordecreaseincreaseintradeandotherreceivables": 23037,
    "adjustmentsfordecreaseincreaseininventories": 960920,
    "adjustmentsfordecreaseincreaseinotherassets": -45065,
    "adjustmentsforincreasedecreaseintradeandotherpayables": 586796,
    "weightedaverageexercisepriceofshareoptionsoutstandinginsharebasedpaymentarrangement1": 0.31,
    "numberofoutstandingshareoption": 45309478,
    "weightedaverageexercisepriceofshareoptionsgrantedinsharebasedpaymentarrangement1": 0.28,
    "numberofshareoptiongrantedinsharebasedpaymentarrangement": 11560000,
    "weightedaverageexercisepriceofshareoptionsexercisedinsharebasedpaymentarrangement1": 0.23,
    "numberofshareoptionsexercisedinsharebasedpaymentsarrangement": -4057640,
    "weightedaverageexercisepriceofshareoptionsforfeitedinsharebasedpaymentarrangement1": 0.5,
    "numberofshareoptionforfeitedinsharebasedpaymentsarrangement": -5000000,
    "weightedaverageexercisepriceofshareoptionsexercisableinsharebasedpaymentarrangement1": 0.31,
    "numberofshareoptionexercisableinsharebasedpaymentarrangement": 45309478,
    "sharebasedcompensationarrangementbysharebasedpaymentawardexpirationdate1": "2024-04-14",
    "exerciseprice": "USD 0.5859",
    "shareoptionsoutstanding": 45309478,
    "shareoptionspershare": 1.58,
    "sharebasedcompensationarrangementbysharebasedpaymentawardawardgrantdate": "2020-10-29",
    "exercisepriceshareoptionsgranted1": 0.12,
    "numberofinstrumentotherequityinstrumentgranted": 11560000,
    "weightedaveragesharepriceshareoptionsgranted1": 0.25,
    "descriptionofexpectedvolatilityshareoptionsgranted": 1.4269999999999998,
    "descriptionofriskfreeinterestrateshareoptionsgranted": 0.0013000000000000002,
    "valuepershareoptionsgranted": 0.2189,
    "optionsissuedunderesop": 1970100,
    "sharebasedpaymentstodirectors": 145913,
    "totalexpenses": 2116013,
    "purchasesofgoodsrelatedpartytransactions": 110607,
    "othertransactionswithkeymanagementrelatedpartytransactions": 110607,
    "paymentstosuppliersforgoodsandservicesandtoandonbehalfofemployees": 70000,
    "othercurrentfinancialliabilities": 152154,
    "impactonlossforperiods": 136467,
    "impactonothercomponentofequity": 5219,
    "expectedcreditlossrate": 0.5357999999999999,
    "grosscarryingamount": 28553,
    "tradeandotherpayable": 132514,
    "grossleaseliabilities": 20498,
    "financialliabilities": 153012,
    "assistancepackages": 154904,
    "usefullivesordepreciationratespropertyplantandequipmentperiod": 3,
    "finishedgoods": 328833,
    "inventoryrawmaterials": 430932,
    "noncurrentrawmaterials": 1266587,
    "randdtaxconcessionrefund": 306154,
    "otherincomeofresearchanddevelopment": 306154,
    "governmentassistancepackages": 161600,
    "researchanddevelopmentsgrants": 74821,
    "informationaboutnatureoflesseesleasingactivities": "In January 2019, the group entered into a three-yearcommercial lease in Blackburn North. The lease is for the use of warehousing and office facilities. This lease includes an extension optionfor a further 3 years by written request to the landlord before 31 December 2021.",
    "paymentforservices": 70000,
    "parvaluepershare": 0.16,
    "revaluationfinancialsamount": 607000,
    "expenseofsharesowed": 73088,
    "numberofsegment": 2,
    "percentageofentityrevenue": 0.1,
    "optiongranteddescription": "Options granted to a former managing director on 11 February 2019 andvalued at $975,000 in the 30 June 2019 financials were subject to shareholder approval. In line with IFRS 2, these were re-measured atgrant date 6 November 2019 after being approved by shareholders with a value of $368,000, being a revaluation of $607,000 in the 30 June2020 financials.",
    "sharesissuedtodirectorsforthedirectorfees": 145913,
    "rentalexpense": 40607,
    "leaserenewed": "January 1, 2019",
    "warehousingdistributionandinvoicingservices": 70000,
    "sharesissuedpricepershare1": 0.16,
    "percentageofforeignexchangerates": 0.049,
    "entityregistrantname": "IMMURON LIMITED",
    "tradingsymbol": "IMRN",
    "documenttype": "20-F",
    "currentfiscalyearenddate": "June 30",
    "entitycommonstocksharesoutstanding": 227246596,
    "amendmentflag": "false",
    "entitycentralindexkey": 1660046,
    "entitycurrentreportingstatus": "Yes",
    "entityvoluntaryfilers": "No",
    "entityfilercategory": "Non-accelerated filer",
    "entitywellknownseasonedissuer": "No",
    "documentperiodenddate": "June 30, 2021",
    "documentfiscalyearfocus": 2021,
    "documentfiscalperiodfocus": "FY",
    "entityemerginggrowthcompany": "true",
    "entityshellcompany": "true",
    "entityextransitionperiod": "false",
    "documentregistrationstatement": "false",
    "documentannualreport": "true",
    "documenttransitionreport": "false",
    "documentshellcompanyreport": "false",
    "entityfilenumber": "000-38104",
    "entityincorporationstatecountrycode": "Australia",
    "entityaddressaddressline1": "Level 3, 62 Lygon Street",
    "entityaddresscityortown": "Carlton South",
    "entityaddresspostalzipcode": 3053,
    "entityaddresscountry": "Australia",
    "contactpersonnelname": "Dr. Jerry Kanellos",
    "cityareacode": 61,
    "localphonenumber": "3 9822 7735",
    "security12btitle": "American Depositary Shares,  each representing 40 Ordinary Shares",
    "securityexchangename": "NASDAQ",
    "entityinteractivedatacurrent": "Yes",
    "documentaccountingstandard": "International Financial Reporting Standards"
  },
  {
    "date": "2020-06-30",
    "symbol": "IMRN",
    "period": "FY",
    "entityregistrantname": "Immuron Ltd",
    "entitycentralindexkey": 1660046,
    "documenttype": "20-F",
    "documentperiodenddate": "2020-06-30",
    "amendmentflag": "false",
    "currentfiscalyearenddate": "--06-30",
    "entitywellknownseasonedissuer": "No",
    "entityvoluntaryfilers": "No",
    "entitycurrentreportingstatus": "Yes",
    "entityinteractivedatacurrent": "Yes",
    "entityfilercategory": "Non-accelerated Filer",
    "entityemerginggrowthcompany": "true",
    "entityextransitionperiod": "false",
    "entityshellcompany": "false",
    "entitycommonstocksharesoutstanding": 178279566,
    "entityfilenumber": "000-38104",
    "documentfiscalperiodfocus": "FY",
    "documentfiscalyearfocus": 2020,
    "entityincorporationstatecountrycode": "C3",
    "documentannualreport": "true",
    "documenttransitionreport": "false",
    "documentshellcompanyreport": "false",
    "revenuefromcontractswithcustomers": 49933,
    "costofsales": 688836,
    "grossprofit": 1829730,
    "otherincome": 154904,
    "othergainslosses": 11335,
    "generalandadministrativeexpense": 3170078,
    "researchanddevelopmentexpense": 1178685,
    "salesandmarketingexpense": -871551,
    "profitlossfromoperatingactivities": -3003839,
    "costoffinance": -21631,
    "financecostsnet": 21631,
    "profitlossbeforetax": -2927206,
    "profitloss": -2927206,
    "othercomprehensiveincomenetoftaxexchangedifferencesontranslation": 102938,
    "comprehensiveincome": -2927206,
    "basicanddilutedearningslosspershare": -1.66,
    "cash": 3250468,
    "tradeandothercurrentreceivables": 327689,
    "inventories": 797690,
    "othercurrentassets": 33194,
    "currentassets": 4409041,
    "propertyplantandequipment": 70773,
    "inventoriestotal": 1722349,
    "noncurrentassets": 1793122,
    "assets": 6202163,
    "tradeandothercurrentpayables": 384397,
    "employeebenefitobligation": 89838,
    "othercurrentliabilities": 42176,
    "currentliabilities": 516411,
    "employeebenefitobligationnoncurrent": 22910,
    "othernoncurrentliabilities": 18929,
    "noncurrentliabilities": 41839,
    "liabilities": 558250,
    "netassetsliabilities": 5643913,
    "issuedcapital": 62426991,
    "otherreserves": 1133345,
    "retainedearnings": -57916423,
    "equity": 5643913,
    "equitybalance": 5643913,
    "changeinaccountingpolicy": -1479,
    "restatedtotalequityat1july2019": -57239058,
    "othercomprehensiveincomelossforperiod": 102938,
    "issueofequity": 1652436,
    "employeeshareschemesvalueofemployee": 73088,
    "optionsorwarrantsissuedexpensed": -484680,
    "optionsorwarrantsforteitedlapsed": 2251320,
    "revaluationofoptionissuedinpriorperiod": -607000,
    "receiptsfromsalesofgoodsandrenderingofservices": 2914614,
    "paymentstosuppliersforgoodsandservice": -6748674,
    "otherinflowsoutflowsofcashclassifiedasoperatingactivities": 531828,
    "revenuefromgovernmentgrants": 154904,
    "cashflowsfromusedinoperatingactivities": -3147328,
    "purchaseofpropertyplantandequipmentclassifiedasinvestingactivities": 864,
    "cashflowsfromusedininvestingactivities": -864,
    "proceedsfromissuingshares": 1957164,
    "capitalcost": 374728,
    "repaymentsofborrowingsclassifiedasfinancingactivities": 366655,
    "paymentsofleaseliabilitiesclassifiedasfinancingactivities": 41390,
    "interestpaidclassifiedasfinancingactivities": 17439,
    "cashflowsfromusedinfinancingactivities": 1156952,
    "increasedecreaseincashandcashequivalents": -1991240,
    "cashandcashequivalents": 107605,
    "effectofexchangeratechangesoncashandcashequivalents": 121821,
    "revenue": 49933,
    "otherincomefromnonoperatingactivities": 473674,
    "operatingleasecommitments": 104851,
    "discountedusinglesseesincrementalborrowingrateofatdateofinitialapplication": 98302,
    "leaseliability": 98302,
    "currentleaseliabilities": 42176,
    "noncurrentleaseliabilities": 18929,
    "increaseingeneralandadministrativeexpenses": 3170078,
    "usefullivesordepreciationratespropertyplantandequipmentperiod": "P3Y",
    "noncurrentrawmaterials": 1722349,
    "randdtaxconcessionrefund": 308225,
    "assistancepackages": 154904,
    "revenueandoperatingincome": 2518566,
    "australianfederalrdtaxconcessionrefund": 308225,
    "othergrants": 154904,
    "otherincomes": 10545,
    "netforeignexchangegainloss": 11335,
    "totalrevenueandotherincome": 3003575,
    "accountingandaudit": 389798,
    "baddebts": 26983,
    "consultingexpenses": 181474,
    "depreciationandamortisationexpense": 44056,
    "employeebenefitsexpense": 1531037,
    "expectedcreditlosses": -3991,
    "insuranceexpense": 469844,
    "investorrelationsexpenses": 197839,
    "legalexpenses": 184382,
    "listingandshareregistry": 212236,
    "utilitiesexpense": 51973,
    "adjustmentsforsharebasedpayments": -533912,
    "superannuationexpenses": 48877,
    "travelexpense": 91347,
    "otherexpensebynature": 278135,
    "sellingexpense": 340046,
    "marketingexpenses": 295261,
    "distributioncosts": 236244,
    "unusedtaxlossesforwhichnodeferredtaxassetrecognised": 40018956,
    "currenttaxexpenseincomeandadjustmentsforcurrenttaxofpriorperiods": 11005213,
    "currenttaxexpenseincome": -804982,
    "taxeffectofresearchanddevelopmenttaxincentive": -84762,
    "taxeffectofaccountingexpendituresubjecttoresearchanddevelopmenttaxincentive": 194855,
    "taxeffectofsharebasedpayments": -146826,
    "taxeffectofexpensenotdeductibleindeterminingtaxableprofittaxlosses": -18678,
    "taxeffectoftaxpayable": -860393,
    "deferredtaxexpenseincomeunrecognisedinprofitorloss": 860393,
    "applicabletaxrate": 0.275,
    "keymanagementpersonnelcompensationshorttermemployeebenefits": 867054,
    "keymanagementpersonnelcompensationpostemploymentbenefits": 29213,
    "keymanagementpersonnelcompensationotherlongtermbenefits": 3610,
    "keymanagementpersonnelcompensationsharebasedpayment": 73088,
    "keymanagementpersonnelcompensation": 972965,
    "weightedaveragenumberofshares": 176393354,
    "cashatbankandinhand": 3250468,
    "currenttradereceivables": 49519,
    "lossonallowancetradereceivables": -30055,
    "currentaccruedincome": 308225,
    "workinprogress": 117576,
    "finishedgoods": 680114,
    "otherassets": 1722349,
    "countryofincorporationorresidenceofsubsidiary": "Canada",
    "proportionofownershipinterestinsubsidiary": 1,
    "tradeandothercurrentpayablestotradesuppliers": 157644,
    "accrualsclassifiedascurrent": 210734,
    "othercurrentpayables": 16019,
    "rightofuseassets": 58095,
    "leaseliabilities": 61105,
    "depreciationrightofuseassets": 38729,
    "interestexpenseonleaseliabilities": 4192,
    "cashoutflowforleases": 41390,
    "informationaboutnatureoflesseesleasingactivities": "In January 2019 the group entered into a three-year commercial lease in Blackburn North. The lease is for the use of warehousing and office facilities. This lease includes an extension option for a further 3 years by written request to the landlord before 31 December 2021.",
    "ordinarysharesfullypaidshares": 178279566,
    "ordinarysharesfullypaidvalue": 62426991,
    "ordinaryshares": 178279566,
    "ordinarysharesvalue": 62426991,
    "issueofequitytoordinaryvalue": 62426991,
    "ordinaryshare": 178279566,
    "issuepursuanttoadspublicoffering": 1926186,
    "issuepursuanttoadspublicofferingshares": 13565200,
    "issueinlieuofpaymentforservices": 100978,
    "issueinlieuofpaymentforservicesshares": 437500,
    "exerciseofnasdaqwarrants": 27,
    "exerciseofnasdaqwarrantsshares": 86240,
    "exerciseofrepresentativewarrant": 540062,
    "exerciseofrepresentativewarrantshares": 974920,
    "transactioncostsarisingonrepresentativewarrantsissued": -55454,
    "businessacquisitioncostoftransactioncost": -374728,
    "paymentforservices": 70000,
    "parvaluepershare": 0.16,
    "currencytranslationdifferences": 102938,
    "othercomprehensiveincome": 102938,
    "sharebasedpaymentexpenses": 73088,
    "optionsandwarrantsissuedexpensed": -484680,
    "optionsandwarrantslapsed": -2251320,
    "revaluationofoptionsissuedinpriorperiod": -607000,
    "valuereservedforissueunderoptionsandcontractsforsaleofshares": 938790,
    "sharesreservedforissueunderoptionsandcontractsforsaleofshares": 42807118,
    "issueofrepresentativewarrantstwo": 55454,
    "issueofrepresentativewarrantstwoshares": 542600,
    "lapseofunexercisedoptionsatzeropointfive": -2086920,
    "lapseofunexercisedoptionsatzeropointfiveshares": -7625532,
    "lapseofunexercisedoptionsatzeropointfivefiveshares": -25289894,
    "lapseofunexercisedoptionsatzeropointfiveone": -164400,
    "lapseofunexercisedoptionsatzeropointfivesharesone": -2000000,
    "exerciseofnasdaqwarrantsatusdtenperfortyoptions": -72,
    "exerciseofnasdaqwarrantsatusdtenperfortyoptionsshares": -218800,
    "exerciseofrepresentativewarrants": -540062,
    "exerciseofrepresentativewarrantsshares": -2065000,
    "expenseofsharesowed": 73088,
    "financecosts": 21631,
    "segmentassets": 6202163,
    "segmentliabilities": -558250,
    "percentageofentitysrevenue": 0.1,
    "adjustmentsfordistributioncosts": 70000,
    "adjustmentsforfinancecosts": 21631,
    "adjustmentsforprovisions": 19717,
    "sharebasedpaymentsexpense": -533912,
    "adjustmentsforunrealisedforeignexchangelossesgains": -18883,
    "adjustmentsfordecreaseincreaseintradeandotherreceivables": 641236,
    "adjustmentsfordecreaseincreaseininventories": -113635,
    "adjustmentsfordecreaseincreaseinotherassets": 16096,
    "adjustmentsforincreasedecreaseintradeandotherpayables": -362437,
    "weightedaverageexercisepriceofshareoptionsoutstandinginsharebasedpaymentarrangement1": 0.4,
    "weightedaverageexercisepriceofshareoptionsgrantedinsharebasedpaymentarrangement1": 0.18,
    "weightedaverageexercisepriceofshareoptionsexercisedinsharebasedpaymentarrangement1": 0.18,
    "weightedaverageexercisepriceofshareoptionsforfeitedinsharebasedpaymentarrangement1": 0.52,
    "weightedaverageexercisepriceofshareoptionsexercisableinsharebasedpaymentarrangement1": 0.4,
    "numberofoutstandingshareoption": 42807118,
    "numberofshareoptiongrantedinsharebasedpaymentarrangement": 542600,
    "numberofshareoptionsexercisedinsharebasedpaymentsarrangement": -424840,
    "numberofshareoptionforfeitedinsharebasedpaymentsarrangement": -36774386,
    "numberofshareoptionexercisableinsharebasedpaymentarrangement": 42807118,
    "sharebasedcompensationarrangementbysharebasedpaymentawardawardgrantdate": "2019-05-23",
    "sharebasedcompensationarrangementbysharebasedpaymentawardexpirationdate1": "2024-05-23",
    "weightedaverageexercisepriceofotherequityinstrumentsoutstandinginsharebasedpaymentarrangement1": 0.125,
    "numberofotherequityinstrumentsoutstandinginsharebasedpaymentarrangements": 42807118,
    "weightedaverageremainingcontractuallifeofoutstandingshareoptionsterm": "P2Y3M11D",
    "exercisepriceshareoptionsgranted1": 0.5,
    "numberofinstrumentotherequityinstrumentgranted": 5000000,
    "weightedaveragesharepriceshareoptionsgranted1": 0.15,
    "descriptionofexpectedvolatilityshareoptionsgranted": 1,
    "descriptionofriskfreeinterestrateshareoptionsgranted": 0.0169,
    "valuepershareoptionsgranted": 0.0736,
    "weightedaveragefairvalueexpectedterm": "P1Y3M29D",
    "exercisepriceofoutstandingshareoptions2019": 0.5,
    "weightedaveragesharepriceshareoptionsgranted2019": 0.315,
    "weightedaverageshareprice2019": 0.0937,
    "numbersofinstrumentotherequityinstrumentgranted": -533912,
    "agreementdescription": "Pursuant to an agreement entered between the Company and a consultant on April 1, 2015, the Company granted 1,000,000 options, which were issued and vested on 9 December 2016, and each option entitles the holder to purchase one ordinary share of the Company at an exercise price of A$0.500. These options were issued and vested following the successful completion of related milestone pertaining to a minimum recruitment of 100 patients into the Company's NASH Phase 2 clinical trial.",
    "optiongranteddescription": "Options granted to Dr Gary Jacob on 11 February 2019 and valued at A$975,000 in the 30 June 2019 financials were subject to shareholder approval. In line with IFRS 2, these were re-valued at grant date 6 November 2019 after being approved by shareholders with a value of A$368,000.",
    "purchasesofgoodsrelatedpartytransactions": 142347,
    "othertransactionswithkeymanagementrelatedpartytransactions": 100978,
    "rentalexpense": 41369,
    "leaserenewed": "2019-01-01",
    "leaseterm": "P3Y",
    "additionalleaseterm": "P3Y",
    "warehousingdistributionandinvoicingservices": 70000,
    "warehousingdistributionandservicesfees": 70000,
    "ordinarysharesissued": 437500,
    "sharesissuedpricepershare1": 0.16,
    "tradereceivables": 45591,
    "tradeandotherpayablestotradesuppliers": 41771,
    "othercurrentfinancialliabilities": 41771,
    "impactonlossforperiods": 99994,
    "impactonothercomponentofequity": 4035,
    "expectedcreditlossrate": 1,
    "grosscarryingamount": 49519,
    "lossallowance": 30055,
    "tradeandotherpayables": 173663,
    "financialliabilities": 237125,
    "percentageofforeignexchangerates": 0.033
  },
  {
    "date": "2019-06-30",
    "symbol": "IMRN",
    "period": "FY",
    "entityregistrantname": "Immuron Ltd",
    "entitycentralindexkey": 1660046,
    "documenttype": "20-F",
    "documentperiodenddate": "2019-06-30",
    "amendmentflag": "false",
    "currentfiscalyearenddate": "--06-30",
    "entitywellknownseasonedissuer": "No",
    "entityvoluntaryfilers": "No",
    "entitycurrentreportingstatus": "Yes",
    "entityinteractivedatacurrent": "Yes",
    "entityfilercategory": "Non-accelerated Filer",
    "entityemerginggrowthcompany": "true",
    "entityextransitionperiod": "false",
    "entityshellcompany": "false",
    "entitycommonstocksharesoutstanding": 163215706,
    "documentfiscalperiodfocus": "FY",
    "documentfiscalyearfocus": 2019,
    "entityincorporationstatecountrycode": "C3",
    "documentannualreport": "true",
    "documenttransitionreport": "false",
    "documentshellcompanyreport": "false",
    "revenuefromcontractswithcustomers": 364,
    "costofsales": 667371,
    "grossprofit": 1720055,
    "otherincome": 1045,
    "othergainslosses": 51807,
    "generalandadministrativeexpense": 5014128,
    "researchanddevelopmentexpense": 1044528,
    "salesandmarketingexpense": -864644,
    "profitlossfromoperatingactivities": -4962321,
    "financeincome": 39,
    "financecostsnet": -39,
    "profitlossbeforetax": -4632743,
    "profitloss": -4962282,
    "othercomprehensiveincomenetoftaxexchangedifferencesontranslation": 61846,
    "comprehensiveincome": -4632743,
    "basicanddilutedearningslosspershare": -3.2,
    "cash": 22801,
    "tradeandothercurrentreceivables": 968926,
    "inventories": 544341,
    "othercurrentassets": 49290,
    "currentassets": 6682444,
    "propertyplantandequipment": 17140,
    "inventoriestotal": 1862063,
    "noncurrentassets": 1879203,
    "assets": 5324489,
    "tradeandothercurrentpayables": 13657,
    "employeebenefitobligation": 103612,
    "currentliabilities": 1195531,
    "employeebenefitobligationnoncurrent": 14980,
    "noncurrentliabilities": 14980,
    "liabilities": 797155,
    "netassetsliabilities": 7351136,
    "issuedcapital": 60511326,
    "otherreserves": 18529,
    "retainedearnings": -56860523,
    "equity": 7351136,
    "equitybalance": -56860523,
    "othercomprehensiveincomelossforperiod": 61846,
    "optionsorwarrantsissuedexpensed": 1343500,
    "issueofequity": 2139183,
    "optionsorwarrantsexercised": -100,
    "optionsorwarrantsforteitedlapsed": 311635,
    "receiptsfromsalesofgoodsandrenderingofservices": 2619477,
    "paymentstosuppliersforgoodsandservices": -5608262,
    "otherinflowsoutflowsofcashclassifiedasoperatingactivities": 1190206,
    "cashflowsfromusedinoperatingactivities": -1798579,
    "purchaseofpropertyplantandequipmentclassifiedasinvestingactivities": 2047,
    "interestreceivedclassifiedasinvestingactivities": 39,
    "cashflowsfromusedininvestingactivities": -2008,
    "proceedsfromissuingshares": 2894238,
    "capitalcost": 825055,
    "cashflowsfromusedinfinancingactivities": 2069183,
    "increasedecreaseincashandcashequivalents": 268596,
    "effectofexchangeratechangesoncashandcashequivalents": 123861,
    "revenueandoperatingincome": 2387426,
    "revenue": 364,
    "otherincomefromnonoperatingactivities": 532050,
    "depreciationandamortisationexpense": 5287,
    "travelexpense": 159911,
    "usefullivesordepreciationratespropertyplantandequipmentperiod": "P5Y",
    "leasecommitmentsforshorttermleaseforwhichrecognitionexemptionhasbeenused": 104851,
    "operatingcashflowswillincreaseandfinancingcashflowsdecrease": 41389,
    "accountingandaudit": 496983,
    "rawmaterials": 225765,
    "noncurrentrawmaterials": 1862063,
    "randdtaxconcessionrefund": 531005,
    "netforeignexchangegainloss": 51807,
    "impairmentloss": 13394,
    "totalrevenueandotherincome": 2957889,
    "baddebts": 50429,
    "consultingexpenses": 243508,
    "employeebenefitsexpense": 1599023,
    "expectedcreditlosses": 34046,
    "insuranceexpense": 307757,
    "investorrelationsexpenses": 128415,
    "legalexpenses": 171145,
    "listingandshareregistry": 186013,
    "utilitiesexpense": 105606,
    "adjustmentsforsharebasedpayments": 1343500,
    "superannuationexpenses": 55176,
    "otherexpensebynature": 127329,
    "sellingexpense": 277478,
    "marketingexpenses": 377427,
    "distributioncosts": 209739,
    "unusedtaxlossesforwhichnodeferredtaxassetrecognised": 37202960,
    "currenttaxexpenseincomeandadjustmentsforcurrenttaxofpriorperiods": 10230814,
    "currenttaxexpenseincome": -1274004,
    "taxeffectofresearchanddevelopmenttaxincentive": -146026,
    "taxeffectofaccountingexpendituresubjecttoresearchanddevelopmenttaxincentive": 335693,
    "taxeffectofsharebasedpayments": 369463,
    "taxeffectofexpensenotdeductibleindeterminingtaxableprofittaxloss": 38656,
    "taxeffectoftaxpayable": -676218,
    "taxeffectofforeigntaxrates": 1539,
    "deferredtaxexpenseincomeunrecognisedinprofitorloss": 674679,
    "keymanagementpersonnelcompensationshorttermemployeebenefits": 952406,
    "keymanagementpersonnelcompensationpostemploymentbenefits": 32300,
    "keymanagementpersonnelcompensationotherlongtermbenefits": 3652,
    "keymanagementpersonnelcompensationsharebasedpayment": 1296400,
    "keymanagementpersonnelcompensation": 2284758,
    "weightedaveragenumberofshares": 144740535,
    "cashatbankandinhand": 5119887,
    "currenttradereceivables": 332972,
    "lossonallowancetradereceivables": -34046,
    "othercurrentreceivables": 138172,
    "currentaccruedincome": 531828,
    "workinprogress": 192399,
    "finishedgoods": 126177,
    "otherassets": 1862063,
    "countryofincorporationorresidenceofsubsidiary": "Canada",
    "proportionofownershipinterestinsubsidiary": 1,
    "tradeandothercurrentpayablestotradesuppliers": 715115,
    "accrualsclassifiedascurrent": 355825,
    "othercurrentpayables": 20979,
    "leasecommitmentsforshorttermleasesforwhichrecognitionexemptionhasbeenused": 63462,
    "rentalexpense": 53958,
    "discriptionofleaseterm": "The property lease is a non-cancellable lease with a 3 year term, with rent payable monthly in advance. The minimum lease payments shall be increased by CPI per annum. An option exists to renew the lease at the end of the 3 year term for an additional term of 3 years. The current 3 year lease period expires in December 2021.",
    "ordinaryshares": 163215706,
    "issueofequitytoordinaryvalue": 60511326,
    "expensefromequitysettledsharebasedpaymenttransactionslieuofpaymentforservices": 70000,
    "expensefromequitysettledsharebasedpaymenttransactionslieuofpaymentforservices1": 70000,
    "expensefromequitysettledsharebasedpaymenttransactionslieuofpaymentforservicesthroughshares1": 437500,
    "proceedsfromissuedatadspublicoffering": 2894238,
    "proceedsfromissuedsharesatadspublicoffering": 20000000,
    "stockissuedduringvaluereclassifytostockoptionsexercised": 100,
    "businessacquisitioncostoftransactioncost": -825055,
    "numberofsharesissued": 32707,
    "parvaluepershare": 0.16,
    "currencytranslationdifferences": 61846,
    "othercomprehensiveincome": 61846,
    "optionsissued": 1343500,
    "expenseofvestedoptions": -100,
    "optionsandwarrantslapsed": -311635,
    "valuereservedforissueunderoptionsandcontractsforsaleofshares": 3681804,
    "sharesreservedforissueunderoptionsandcontractsforsaleofshares": 77443744,
    "valueissuedemployeestockownershipplanunlistedoption": 204100,
    "numberofsharesissueemployeestockownershipplanunlistedoption": 1300000,
    "valueissuedemployeestockownershipplanunlistedoptionone": 164400,
    "numberofsharesissueemployeestockownershipplanunlistedoptionone": 2000000,
    "valueissuedlapseofemployeestockownershipplanunlistedoption": -98385,
    "numberofsharesissuelapseofemployeestockownershipplanunlistedoption": -1050000,
    "valueissuedemployeestockownershipplanunlistedoptiontwo": 975000,
    "numberofsharesissueemployeestockownershipplanunlistedoptiontwo": 5000000,
    "numberofvalueissuelapseofunlistedoptionone": -185601,
    "numberofsharesissuelapseofunlistedoptionone": -1000000,
    "numberofvalueissuelapseofunlistedoptiontwo": -1173,
    "numberofsharesissuelapseofunlistedoptiontwo": -15380,
    "numberofvalueissuelapseofunlistedoptionthree": -13390,
    "numberofsharesissuelapseofunlistedoptionthree": -140056,
    "numberofvaluesreclassifyexcercisedoptionfromreservetosharecapital": -100,
    "numberofvaluesreclassifyexcercisedoptionfromreservetoaccumulatedlosses": -13086,
    "segmentassets": 5324489,
    "segmentliabilities": -797155,
    "percentageofentitysrevenue": 0.1,
    "numberofsegment": 2,
    "adjustmentsfordistributioncosts": 70000,
    "adjustmentsforfinanceincome": -39,
    "adjustmentsforprovisions": 4580,
    "sharebasedpaymentsexpense": 1343500,
    "adjustmentsforunrealisedforeignexchangelossesgains": -62015,
    "adjustmentsfordecreaseincreaseintradeandotherreceivables": 680337,
    "adjustmentsfordecreaseincreaseininventories": 263365,
    "adjustmentsfordecreaseincreaseinotherassets": 92510,
    "adjustmentsforincreasedecreaseintradeandotherpayables": 402593,
    "numberofoutstandingshareoptions": 77443744,
    "numberofshareoptionsgrantedinsharebasedpaymentarrangement": 8300000,
    "numberofshareoptionsforfeitedinsharebasedpaymentarrangement": 2205436,
    "numberofshareoptionsexercisableinsharebasedpaymentarrangement": 77443744,
    "weightedaverageexercisepriceofshareoptionsoutstandinginsharebasedpaymentarrangement1": 0.42,
    "weightedaverageexercisepriceofshareoptionsgrantedinsharebasedpaymentarrangement1": 0.5,
    "weightedaverageexercisepriceofshareoptionsforfeitedinsharebasedpaymentarrangement1": 0.53,
    "weightedaverageexercisepriceofshareoptionsexercisableinsharebasedpaymentarrangement1": 0.42,
    "sharebasedcompensationarrangementbysharebasedpaymentawardawardgrantdate": "2019-02-11",
    "sharebasedcompensationarrangementbysharebasedpaymentawardexpirationdate1": "2024-02-10",
    "weightedaverageexercisepriceofotherequityinstrumentsoutstandinginsharebasedpaymentarrangement1": 0.5,
    "numberofotherequityinstrumentsoutstandinginsharebasedpaymentarrangements": 5000000,
    "weightedaverageremainingcontractuallifeofoutstandingshareoptionsterm": "P2Y0M0D",
    "exercisepriceshareoptionsgranted1": 0.5,
    "numberofinstrumentsotherequityinstrumentsgranted": 5000000,
    "weightedaveragesharepriceshareoptionsgranted1": 0.29,
    "descriptionofexpectedvolatilityshareoptionsgranted": 1,
    "descriptionofriskfreeinterestrateshareoptionsgranted": 0.0169,
    "valuepershareoptionsgranted": 0.195,
    "vestingdate": "P0Y0M0D",
    "weightedaveragefairvalueexpectedterm": "P1Y3M29D",
    "exercisepriceofoutstandingshareoptions2019": 0.5,
    "weightedaveragesharepriceshareoptionsgranted2019": 0.315,
    "weightedaverageshareprice2019": 0.0937,
    "warrantsexercisabledescription": "Warrants are exercisable at US$10.00 per 40 options, i.e. US$0.25 per option.",
    "agreementdescription": "Pursuant to an agreement entered between the Company and a consultant on April 1, 2015, the Company granted 1,000,000 options, which were issued and vested on 9 December 2016, and each option entitles the holder to purchase one ordinary share of the Company at an exercise price of A$0.500. These options were issued and vested following the successful completion of related milestone pertaining to a minimum recruitment of 100 patients into the Company’s NASH Phase 2 clinical trial.",
    "purchasesofgoodsrelatedpartytransactions": 123958,
    "othertransactionswithkeymanagementrelatedpartytransactions": 70000,
    "leaserenewed": "2019-01-01",
    "leaseterm": "P3Y",
    "additionalleaseterm": "P3Y",
    "warehousingdistributionandservicesfees": 70000,
    "ordinarysharesissued": 437500,
    "sharesissuedpricepershare1": 0.16,
    "othercurrentfinancialliabilities": 13657,
    "impactonlossforperiods": 362634,
    "impactonothercomponentofequity": 1334,
    "expectedcreditlossrate": 0.9164,
    "grosscarryingamount": 332972,
    "lossallowance": 34046,
    "financialliabilities": 1091919,
    "percentageofforeignexchangerate": 0.069
  }
]